Robert Hoy, PA
Physician Assistant · Tucson, AZNPI 1124351655
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $31,743 of the $41,496 with a category attached, or 76.5%. Johnson & Johnson accounts for 71.7% of it on its own, with 33 other manufacturers making up the rest. Reporting peaked in 2021 at $13,651 and has fallen 91.0% since, to $1,234 in 2025. Among physician assistant clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 252 payments — averaging $164.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$30K
- Dendreon Pharmaceuticals LLC$7K
- Accord Healthcare, Inc.$2K
- Astellas Pharma US Inc$601
- Bayer$452
- Sumitomo Pharma America, Inc.$411
- plus $2K from 28 others
What the payments were for
- Speaking & faculty fees$31,74376%
- Travel & lodging$3,6119%
- Food & beverage$5,75714%
- Education$3861%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 55 | $29,736 |
| Dendreon Pharmaceuticals LLC | 42 | $6,645 |
| Accord Healthcare, Inc. | 5 | $1,607 |
| Astellas Pharma US Inc | 18 | $601 |
| Bayer | 22 | $452 |
| Sumitomo Pharma America, Inc. | 18 | $411 |
| Pfizer | 17 | $359 |
| Myovant Sciences Inc. | 12 | $237 |
| Tempus AI, Inc | 8 | $221 |
| AbbVie(2 entities) | 7 | $145 |
| Axonics, Inc. | 1 | $98 |
| Amgen | 5 | $96 |
| Tolmar Pharmaceuticals, Inc. | 5 | $92 |
| Teleflex LLC | 3 | $67 |
| Ferring Pharmaceuticals Inc. | 3 | $67 |
| Calyxo, Inc. | 4 | $59 |
| Novartis | 2 | $59 |
| Blue Earth Diagnostics | 2 | $58 |
| Progenics Pharmaceuticals, Inc. | 2 | $57 |
| Sun Pharmaceutical Industries Inc. | 3 | $57 |
| Urogen Pharma, Inc. | 3 | $56 |
| Tolmar, Inc. | 2 | $56 |
| Janssen Scientific Affairs, LLC | 1 | $35 |
| Verity Pharmaceuticals Inc. | 2 | $31 |
| Medtronic | 1 | $30 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $23 |
| AstraZeneca | 1 | $23 |
| Immunitybio, Inc. | 1 | $22 |
| Myriad Genetic Laboratories, Inc. | 1 | $21 |
| Organon | 1 | $20 |
| Merck | 1 | $17 |
| Coloplast | 1 | $16 |
| Boston Scientific | 1 | $15 |
| Convatec Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$41,496 in reported general payments places this provider in the 95th percentile of 2,888 physician assistant providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XtandiEnzalutamide | 219 | $3,041,176 |
| NubeqaDarolutamide | 55 | $709,538 |
| ErleadaApalutamide | 29 | $433,346 |
| OrgovyxRelugolix | 82 | $215,403 |
| GemtesaVibegron | 148 | $144,070 |
| MyrbetriqMirabegron | 70 | $82,965 |
| Tamsulosin Hcl | 828 | $12,709 |
| Abiraterone Acetate | 39 | $12,682 |
| Finasteride | 465 | $6,224 |
| Trospium Chloride | 63 | $4,326 |
| Potassium Citrate ErPotassium Citrate | 35 | $2,625 |
| Estradiol | 38 | $2,248 |
| Dutasteride | 59 | $2,123 |
| Testosterone | 15 | $1,576 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 47 | $1,334 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncXtandi, Myrbetriq | $601 | $3,124,140289 claims |
| BayerNubeqa | $452 | $709,53855 claims |
| Johnson & JohnsonErleada | $29,736 | $433,34629 claims |
| Sumitomo Pharma America, Inc.Orgovyx, Gemtesa | $411 | $359,472230 claims |
| Janssen Scientific Affairs, LLCAbiraterone Acetate | $35 | $12,68239 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,888 physician assistant providers in Arizona.
Other physician assistant in Tucson
- Nicole StokerTucson$61K
- Luis LozanoTucson$31K
- Christy HallTucson$30K
- Jenna HiltonGilbert$637K
- Kara GoodingScottsdale$625K
- Ginna GranrothScottsdale$211K
- Nicole MaderaGlendale$128K
- Candace RyanGlendale$113K
- Christopher BeroScottsdale$81K
- Katherine MinorPhoenix$76K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.